ID: ALA5218631

Max Phase: Preclinical

Molecular Formula: C17H15N5O2

Molecular Weight: 321.34

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1cccc(-c2cc3ncnc(N)c3cc2C(N)=O)c1

Standard InChI:  InChI=1S/C17H15N5O2/c1-9(23)22-11-4-2-3-10(5-11)12-7-15-14(6-13(12)17(19)24)16(18)21-8-20-15/h2-8H,1H3,(H2,19,24)(H,22,23)(H2,18,20,21)

Standard InChI Key:  APSBNHLAVUNUOP-UHFFFAOYSA-N

Associated Targets(Human)

PI4-kinase type II 62 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PI4-kinase alpha subunit 184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PI4-kinase beta subunit 1593 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.34Molecular Weight (Monoisotopic): 321.1226AlogP: 1.94#Rotatable Bonds: 3
Polar Surface Area: 123.99Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.45CX LogP: 0.93CX LogD: 0.93
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.68Np Likeness Score: -0.99

References

1. Misehe M, Klima M, Matoušová M, Chalupská D, Dejmek M, Šála M, Mertlíková-Kaiserová H, Boura E, Nencka R..  (2022)  Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold.,  76  [PMID:36184029] [10.1016/j.bmcl.2022.129010]

Source